Erenumab-aooe - Drug Details
๐Ÿ“Š Estimates Erenumab-aooe Dialyzability By Different_Modalities

Erenumab-aooe

Complete Drug Information

Drug Name
Erenumab-aooe
Trade Names
Aimovig
Pregnancy Category
AU: B1
Bioavailability
82% (estimated)
Routes of Administration
Subcutaneous injection
Metabolism
Proteolysis
Elimination
28 days
Formula
C6472H9964N1728O2018S50
Molar Mass
145871.98
Volume of Distribution
C6472H9964N1728O2018S50

๐Ÿคฐ Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.